• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A single dose study of the effects of fenoldopam and enalapril in mild hypertension.

作者信息

MacDonald T M, Jeffrey R F, Freestone S, Lee M R

机构信息

Department of Clinical Pharmacology, Royal Infirmary, Edinburgh, UK.

出版信息

Eur J Clin Pharmacol. 1991;40(3):231-6. doi: 10.1007/BF00315201.

DOI:10.1007/BF00315201
PMID:1676367
Abstract

To clarify the contribution made by the renin-angiotensin system activation to the short lived hypotensive response to fenoldopam, the haemodynamic effects of a combination of fenoldopam (100 mg) and enalapril (5 mg) were compared with fenoldopam alone, enalapril alone and placebo in a balanced, randomised, double blind, single dose study in eight hypertensive patients. Fenoldopam caused an acute fall in blood pressure which lasted approximately 3 h after dosing and was associated with a reflex tachycardia. Enalapril caused a more gradual fall in blood pressure (onset 2 h) without a reflex tachycardia. The combination of drugs produced greater reductions in blood pressure sustained for a longer period than fenoldopam alone and with a more rapid onset than enalapril alone. In combination the hypotensive effects of fenoldopam and enalapril were clearly additive and not synergistic. Activation of the renin-angiotensin system does not antagonise significantly the hypotensive effect of fenoldopam.

摘要

相似文献

1
A single dose study of the effects of fenoldopam and enalapril in mild hypertension.
Eur J Clin Pharmacol. 1991;40(3):231-6. doi: 10.1007/BF00315201.
2
Diuretic and natriuretic properties of fenoldopam in chronic renal failure.非诺多泮在慢性肾衰竭中的利尿和利钠特性。
J Hypertens Suppl. 1989 Dec;7(6):S326-7. doi: 10.1097/00004872-198900076-00159.
3
Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.多巴胺与非诺多泮对正常及原发性高血压受试者肾血流量和前列环素排泄影响的比较。
J Clin Endocrinol Metab. 1989 Dec;69(6):1116-21. doi: 10.1210/jcem-69-6-1116.
4
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.静脉注射非诺多泮与硝普钠治疗重度高血压对肾脏及血流动力学的影响
Circulation. 1990 Mar;81(3):970-7. doi: 10.1161/01.cir.81.3.970.
5
Fenoldopam infusion for the treatment of postoperative hypertension.使用非诺多泮静脉输注治疗术后高血压。
J Clin Anesth. 1993 Sep-Oct;5(5):386-91. doi: 10.1016/0952-8180(93)90102-k.
6
The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.非诺多泮对慢性肾衰竭患者肾血流动力学及尿钠排泄的影响
Neth J Med. 1990 Jun;36(5-6):267-78.
7
Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.非诺多泮而非硝普钠可改善肾功能受损的重度高血压患者的肾功能。
Am J Med. 1993 Aug;95(2):161-8. doi: 10.1016/0002-9343(93)90256-o.
8
Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.健康受试者对新型口服多巴胺激动剂非诺多泮的心血管反应。
J Hypertens Suppl. 1985 Dec;3(3):S173-5.
9
Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis.静脉注射非诺多泮治疗高血压危象患者的血流动力学特征
Clin Investig. 1993 Dec;72(1):60-4. doi: 10.1007/BF00231120.
10
Effects of intravenous fenoldopam (SK&F 82526-J) on blood pressure in severe hypertension. SK&F Fenoldopam Working Group.静脉注射非诺多泮(SK&F 82526-J)对重度高血压患者血压的影响。SK&F非诺多泮研究工作组。
Cardiovasc Drugs Ther. 1992 Aug;6(4):445-6. doi: 10.1007/BF00054195.

引用本文的文献

1
Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.非诺多泮:其药效学和药代动力学特性以及在高血压急症和紧急情况管理中的静脉临床应用潜力综述。
Drugs. 1997 Oct;54(4):634-50. doi: 10.2165/00003495-199754040-00008.
2
Pharmacokinetic drug interactions with ACE inhibitors.与血管紧张素转换酶抑制剂的药代动力学药物相互作用。
Clin Pharmacokinet. 1993 Jul;25(1):20-58. doi: 10.2165/00003088-199325010-00003.

本文引用的文献

1
Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.非诺多泮对人原发性高血压患者外周多巴胺-1受体的选择性刺激作用
J Clin Invest. 1984 Dec;74(6):2198-207. doi: 10.1172/JCI111646.
2
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.多巴胺受体激动剂(非诺多泮)对原发性高血压患者的即时血流动力学影响。
Circulation. 1984 Jun;69(6):1142-5. doi: 10.1161/01.cir.69.6.1142.
3
A new oral renal vasodilator, fenoldopam.
Clin Pharmacol Ther. 1983 Sep;34(3):309-15. doi: 10.1038/clpt.1983.173.
4
Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526.肾血管扩张剂在高血压和肾脏疾病中的潜在用途:SK&F 82526
Fed Proc. 1983 Feb;42(2):186-90.
5
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.新型多巴胺受体激动剂SK&F 82526的外周及中枢效应特征
J Pharmacol Exp Ther. 1982 Nov;223(2):305-13.
6
Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.一种用于血管紧张素I的放射免疫测定法在正常人体血浆肾素活性生理测量中的应用。
J Clin Endocrinol Metab. 1969 Oct;29(10):1349-55. doi: 10.1210/jcem-29-10-1349.
7
Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension.卡托普利50毫克、氢氯噻嗪25毫克每日一次给药及其联合用药治疗轻至中度高血压的对比研究。
Br J Clin Pharmacol. 1987;23 Suppl 1(Suppl 1):89S-92S. doi: 10.1111/j.1365-2125.1987.tb03127.x.
8
The role of alpha-adrenoceptor blockade in the antihypertensive effects of fenoldopam in humans.α-肾上腺素能受体阻断在非诺多泮对人体降压作用中的作用。
Clin Pharmacol Ther. 1988 Jul;44(1):49-55. doi: 10.1038/clpt.1988.111.
9
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients.多巴胺1受体激动剂静脉注射非诺多泮在高血压患者中的药代动力学和药效学特性。
Br J Clin Pharmacol. 1988 Jan;25(1):17-21. doi: 10.1111/j.1365-2125.1988.tb03276.x.
10
Continuous intragastric delivery of fenoldopam: relationship between plasma concentration and effects on renal function.非诺多泮持续胃内给药:血浆浓度与对肾功能影响之间的关系。
Br J Clin Pharmacol. 1988 Mar;25(3):367-73. doi: 10.1111/j.1365-2125.1988.tb03315.x.